Suraksha Diagnostic Limited – Globe Capital Market LTD.
Suraksha Diagnostic Limited
Closed
Price Band
₹420 to ₹441 per share
IPO Issue Period
November 29, 2024 to December 3, 2024
Issue Size
₹846.25 Cr
Face value
₹2 per share
Fresh issue
NIL
Offer for sale
₹846.25 Cr
Minimum Shares for Retail
34 Shares
Listing on
BSE, NSE
Issue Type
Book Built Issue IPO
Registrar to the Issue
Kfin Technologies Limited
Tentative Listing Date
Friday, December 6, 2024
QIB
50%
NII
15%
Retail
35%

ICICI Securities Limited
Nuvama Wealth Management Limited
SBI Capital Markets Limited

Suraksha Diagnostic Limited is a public limited company based in Kolkata, West Bengal, India, originally incorporated as Suraksha Diagnostic Private Limited in 2005. The company specializes in providing a comprehensive range of diagnostic services, including clinical laboratory tests, imaging services, and preventive health check-ups. Led by prominent figures such as Dr. Somnath Chatterjee, Ritu Mittal, and Satish Kumar Verma, Suraksha Diagnostic aims to leverage advanced technology and skilled professionals to deliver accurate and timely results. Positioned as a key player in the growing diagnostics sector, Suraksha Diagnostic is well-equipped to meet the increasing demand for healthcare services driven by rising health awareness. With plans to expand its service offerings and network, the company is poised for significant growth, contributing to the evolving healthcare landscape in India.

For the year/period ended (Rs. in Cr.)

FY24 FY23 FY22
Total Revenue 218.7 190.1 223.2
Profit After Tax 23.5 6.5 20.9
EPS 4.43 1.22 3.91
OPM (%) 32.04% 23.10% 28.08%
PATM (%) 10.57% 3.37% 9.25%

 

For year/ period ended ( in Cr.)

Company Name Market Cap (Cr.) Price P/BV P/E Sales (Cr.)
FY23
Net Profits(Cr.)
FY23
Suraksha Diagnostic Ltd. 846.25 441 13.10 99.55 222.3 23.5
Dr. Lal Pathlabs Ltd. 25894.94 3098.25 10.5 52.8 2226.64 362.29
Metropolis Healthcare Ltd. 11054.01 2156.15 8.13 69.19 1207.71 128.46
Thyrocare Technologies Ltd. 5395.24 1018.5 6 44.13 571.88 69.49
Vijaya Diagnostic Centre Ltd. 11876.28 1157.2 9.91 54.69 547.81 119.64

 

 

 

  • Established Reputation
  • Comprehensive Service Range
  • Advanced Technology
  • Skilled Workforce
  • Focus on Innovation
  • Strong Management Team
  • Robust Network
  • Raise Capital
  • Debt Repayment & Working Capital
  • Investment in Technology
  • Expansion of Network
  • Brand Building & Strengthen Market Position
  • Strategic Acquisitions

The company operates in healthcare diagnosis sector where many renowned and big companies are operating. At the upper Price of INR 441, the company is expected to list at P/E of 99.6 and P/B of 13.1. There are many peers which are cheaper than this company on P/E and P/B metrics. Hence, we maintain a “Neutral” stance due to relatively higher valuation

Be a Part of IPO Success Stories!

Never Miss IPO Investment